Dr. Margaret Hamburg, Commissioner of the US Food and Drug Administration (FDA), will deliver the opening keynote address to more than 8,000 professionals from the biopharmaceutical and related sectors at the Drug Information Association (DIA) 46th Annual Meeting.
Horsham, PA (Vocus) November 4, 2009 -- Dr. Margaret Hamburg, Commissioner of the US Food and Drug Administration (FDA), will deliver the opening keynote address to more than 8,000 professionals from the biopharmaceutical and related sectors at the Drug Information Association (DIA) 46th Annual Meeting.
The DIA 46th Annual Meeting will take place June 13-17, 2010 in Washington, DC. The DIA Annual Meeting is the premier event to attend each year by professionals from the biopharmaceutical and related sectors, as well as regulatory professionals from around the world. There is no other event of its kind that can rival the breadth and depth of experience that this meeting delivers. With 25 content areas and 350 sessions, the presentations are geared to all experience levels and functional areas.
“Dr. Hamburg is an inspiring public health leader with broad experience in public health and medicine, infectious disease, bioterrorism and emergency preparedness,” says DIA Worldwide Executive Director Paul Pomerantz. “We are delighted to have her open our 46th Annual Meeting in Washington DC—home of FDA and the global center of public health policy.”
Dr. Margaret Hamburg was nominated by President Barack Obama for the FDA Commissioner on March 25, 2009 and on May 18, 2009 became the 21st Food and Drug Commissioner. She previously served as the assistant secretary for planning and evaluation in the U.S. Department of Health and Human Services under President Clinton, and as the assistant director of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.
In 2001, Dr. Hamburg became Vice President for Biological Programs at the Nuclear Threat Initiative, a foundation dedicated to reducing the threat to public safety from nuclear, chemical, and biological weapons. In that position, she advocated for broad reforms in public health infrastructure and policy, from local health departments to the national agency, in order to meet the dangers of modern bioterrorism as well as the threats of naturally occurring infectious diseases such as pandemic flu. Dr. Hamburg is only the second woman to serve as FDA commissioner in the agency’s 100-year history.
Register for the 46th Annual Meeting.
About the Drug Information Association (DIA)
A non-profit, neutral, multidisciplinary, global, member-driven association, DIA serves more than 30,000 professionals involved in the biopharmaceutical industry, academia, research organizations and governmental bodies worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of drug development and medical product lifecycle management. DIA is led by its volunteer Board of Directors and executive management team, has headquarters in Horsham, PA, USA, and offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China. For more information, visit www.diahome.org or call 215-442-6100.
Joe.Krasowski (at) diahome (dot) org
Devine + Powers
lmacnichol (at) devinepowers (dot) com
Read the full story at http://www.prweb.com/releases/dia-meeting/margaret-hamburg/prweb3156974.htm.
Copyright©2009 Vocus, Inc.
All rights reserved